Advertisement
About Tengion
Tengion, a clinical stage biotechnology company, has pioneered theAutologous Organ Regeneration Platform(TM) that catalyzes the body's innateability to regenerate. Tengion's neo-organs and neo-tissues, such as bladdersand vessels, combine biocompatible materials and a patient's own (autologous)cells to replace and regenerate failing organs and tissues. Tengion'sproducts have the potential to cure -- rather than treat -- organ and tissuefailure, enabling people to lead healthier lives without donor transplants orthe side effects of related therapies. For more information on the companyand current clinical trials, visit Tengion online at: http://www.tengion.com.
SOURCE Tengion Inc.